Open access
Sep 2026
Reassessment of Neuroprotective Efficacy of TUDCA in Ischemic Stroke: A Multi-Model In Vivo and In Vitro Study
Ischemic stroke accounts for 87% of all strokes and remains a leading cause of mortality and morbidity worldwide, yet therapeutic options remain limited. Emerging evidence on the gut-brain axis and microbial metabolites as modulators of stroke outcome has positioned tauroursodeoxycholic acid (TUDCA), a taurine-conjugat...
Seyedeh Maryam Mousavi, Sumeyra Nuran Ozmen, M. A. Adedokun et al.
· International Journal of Mol... · 0 citations